Depression News and Research

Latest Depression News and Research

Burnham renamed to honor T. Denny Sanford's support

Burnham Institute for Medical Research (Burnham) announced today that philanthropist T. Denny Sanford has pledged $50 million to support and further expand and accelerate the Institute's leading-edge medical research. To honor Sanford, Burnham, has been renamed the Sanford-Burnham Medical Research Institute. This is the second gift Sanford has made to Burnham. In 2007, he directed $20 million through Sanford Health to create the Sanford Children's Health Research Center at Burnham.

27 Jan 2010

Health Canada approves first post-surgical treatment for patients with gastrointestinal stromal tumours

Patients with gastrointestinal stromal tumours (GIST) can now take action at an earlier stage of this rare form of cancer to reduce the risk of their disease returning following surgery. Novartis Pharmaceuticals Canada announced today that Gleevec* (imatinib mesylate) has received conditional approval by Health Canada for the adjuvant (post-surgical) treatment of adult patients who are at intermediate to high risk of disease recurrence following the surgical removal of GIST.

27 Jan 2010

Researching treatments shows paths to health savings

An orthopedic surgeon in Sacramento became suspicious of a new therapy that helps tendons heal by injecting platelet-rich plasma into joints, The Sacramento Bee reports. So, he decided to do a test. It turned out, his patients outcomes were no different when he used the platelet-rich plasma therapy as when he didn't. The plasma treatment costs hundreds of dollars more per patient.

27 Jan 2010

Scott & White conducts DBS research for Parkinson's patients

At Scott & White Memorial Hospital, a multi-disciplinary team of neurosurgeons, neurologists, neurophysiologist, neuropsychologists and a movement disorders specialist are offering hope to some Parkinson's patients with a treatment called Deep Brain Stimulation (DBS). DBS involves placing a thin wire that carries electrical currents deep within the brain on Parkinson's patients who are no longer benefitting from medications, and have significant uncontrollable body movements called dyskinesia. Scott & White is also performing research into the effects of DBS on the non-motor symptoms of Parkinson's disease including "drenching sweats," bladder dysfunction, depression, hallucination, anxiety, and dementia as well as intestinal disorders, loss of sense of smell, and sleep disturbances.

27 Jan 2010

Testing DBS for treating severe long-term depression

Bewernick and colleagues administered DBS treatment in ten patients with severe long-term depression who had not responded to multiple other antidepressant treatments, including psychotherapy, drug treatments and electroconvulsive treatment. After one year of DBS, all patients showed some improvement, and half of them experienced significant improvement in their symptoms of depression, astonishing considering they had not responded to any prior antidepressant treatment. In addition, the patients showed reduced ratings of anxiety and had only minor side effects. Importantly, none of their overall brain functioning was impaired by the DBS treatment.

27 Jan 2010

Insertion of tiny heart pump without surgery

Cardiologists at the University of Illinois Medical Center at Chicago are leading the Midwest in offering improved treatment options to patients, from the most advanced techniques in angioplasty, to lowering the amount of radiation exposure during heart scans, to opening an innovative clinic that treats heart disease and depression together.

23 Jan 2010

UK Gill Heart Institute offers individualized fitness program for heart patients

How do you change health habits among a population with some of the highest heart disease rates in the world? Tackling heart disease in Kentucky - an epicenter of heart health problems - the University of Kentucky Gill Heart Institute Cardiac Rehabilitation Program is helping high-risk patients make radical, lasting changes to improve their heart health.

23 Jan 2010

Ampyra receives FDA approval for improving walking in MS patients

The U.S. Food and Drug Administration today approved Ampyra (dalfampridine) extended release tablets to improve walking in patients with multiple sclerosis (MS). In clinical trials, patients treated with Ampyra had faster walking speeds than those treated with an inactive pill (placebo). This is the first drug approved for this use.

23 Jan 2010

NIH awards grants to develop new tobacco-related drug therapies

Four scientists at Barrow Neurological Institute at St. Joseph's Hospital and Medical Center have been awarded more than $2.2 million from the National Institutes of Health (NIH) to research the effects of nicotine and develop new tobacco-related drug therapies.

22 Jan 2010

Update on the status of Somaxon Pharmaceuticals' NDA for Silenor provided

Somaxon Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the in-licensing, development and commercialization of proprietary branded pharmaceutical products and late-stage product candidates for the treatment of diseases and disorders in the central nervous system therapeutic area, today provided an update on the status of its New Drug Application (NDA) for Silenor® (doxepin) for the treatment of insomnia.

22 Jan 2010

MaMayo Clinic experts available to discuss health issues and concerns related to Olympic Games

Mayo Clinic's medical experts are sources of in-depth expertise and commentary about health issues and background related to the Olympic Games and Olympians. Below is a sampling of Mayo Clinic experts available to discuss numerous topics related to the Olympic Games, including concussions, performance enhancing drugs, sports psychology, joint injuries, etc. Mayo has satellite capability for broadcast requests.

21 Jan 2010

One-third of parents give primary schools an ‘A’; less than one-fourth give secondary schools an ‘A’

School psychologists, counselors and social workers are often the first line of support for children with behavioral, emotional or family problems. Problems can range from attention deficit disorder and homelessness to depression and bullying all of which can make academic success a challenge.

21 Jan 2010

Discovery of new class of compounds may help fight hepatitis C

Stanford University School of Medicine scientists have discovered a novel class of compounds that, in experiments in vitro, inhibit replication of the virus responsible for hepatitis C. If these compounds prove effective in infected humans as well, they may dramatically accelerate efforts to confront this virus’s propensity to rapidly acquire drug resistance, while possibly skirting some of the troubling side effects common among therapies in current use and in late-stage development.

21 Jan 2010

Training health personnel in emotional intelligence can help women from developing depressive symptoms

The extent of mental health problems is increasing, and has become one of the biggest challenges facing Europe today. As much as 10-25 per cent of women are at risk of developing serious depression during their lifetime.

21 Jan 2010

Blue Shield of California to offer Healthways' SilverSneakers Fitness Program to Medicare beneficiaries

Blue Shield of California announced today that it will expand its contract with Healthways, Inc. to offer the SilverSneakers® Fitness Program to Blue Shield Medicare Advantage members in San Bernardino County.

21 Jan 2010

Tel Aviv University finds estrogen may protect women from psychosis

Many American women are prescribed estrogen to combat the negative effects of menopause, such as bone loss and mood swings. Now, new evidence from a Tel Aviv University study suggests that hormone replacement therapy might also protect them ― and younger women ― from schizophrenia as well.

21 Jan 2010

Local physicians are currently recruiting PTSD patients for clinical research study

Researchers are currently recruiting patients with civilian post-traumatic stress disorder (PTSD) for a clinical research study called the COPE study. People who are having symptoms after experiencing a traumatic event or who have been diagnosed with PTSD may be eligible to participate in this study of a new investigational drug.

21 Jan 2010

Afro-American fathers with depressive symptoms are less likely to spend time with their children

African-American fathers who do not live with their sons and who suffer from depression are less likely to spend time with them, according to a University of Michigan study.

21 Jan 2010

Research shows controlled breathing can reduce pain

Research performed by a scientist at Barrow Neurological Institute at St. Joseph's Hospital and Medical Center has shown that controlled breathing at a slowed rate can significantly reduce feelings of pain.

21 Jan 2010

New study may help develop assessment tests in social-emotional learning

Neurobehavioral researchers at Rush University Medical Center have found three key factors in a child's behavior that can lead to social rejection. The studies are a crucial step in developing scientifically sound screening tests and treatment planning for social-emotional learning difficulties.

20 Jan 2010

Depression News and Research

Latest Depression News and Research

Burnham renamed to honor T. Denny Sanford's support

Health Canada approves first post-surgical treatment for patients with gastrointestinal stromal tumours

Researching treatments shows paths to health savings

Scott & White conducts DBS research for Parkinson's patients

Testing DBS for treating severe long-term depression

Insertion of tiny heart pump without surgery

UK Gill Heart Institute offers individualized fitness program for heart patients

Ampyra receives FDA approval for improving walking in MS patients

NIH awards grants to develop new tobacco-related drug therapies

Update on the status of Somaxon Pharmaceuticals' NDA for Silenor provided

MaMayo Clinic experts available to discuss health issues and concerns related to Olympic Games

One-third of parents give primary schools an ‘A’; less than one-fourth give secondary schools an ‘A’

Discovery of new class of compounds may help fight hepatitis C

Training health personnel in emotional intelligence can help women from developing depressive symptoms

Blue Shield of California to offer Healthways' SilverSneakers Fitness Program to Medicare beneficiaries

Tel Aviv University finds estrogen may protect women from psychosis

Local physicians are currently recruiting PTSD patients for clinical research study

Afro-American fathers with depressive symptoms are less likely to spend time with their children

Research shows controlled breathing can reduce pain

New study may help develop assessment tests in social-emotional learning

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Depression News and Research

Latest Depression News and Research

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Newsletters you may be interested in